Owlet Q3'26 Earnings Conference Call - OWLET INC

Explicit Guidance:

• Withdrew: Full-year 2026 guidance (previously: Revenue $118–$122M, Gross Margin 53–55%, Adjusted EBITDA $10.75–$11.75M) due to uncertainty surrounding the Q4 safety update timeline and demand impacts.
• Reaffirmed: 2027 guidance is valid, citing core sell-through pacing ahead of plan and subscription progress as anticipated.
• Q4 2026 Financial Estimates (Non-GAAP/Impact Specifics):
  • Direct Program Costs: $7–$10M for production, shipping, logistics, customer support, and legal/consulting fees related to replacement cable guards.
  • Retailer Returns (Revenue Reduction): $9–$12M expected for existing inventory without replacement guards.
  • Recovery Asset: Estimated $3–$4M asset for returned inventory deemed reworkable for future resale.
  • Replenishment Revenue (Offset): Expected initial load-in of $2–$5M once retailers receive units with new guards.
  • Net Impact: Estimated $13–$18M negative impact on Q4 2026 results excluding potential insurance recovery.
  • Insurance Recovery: Potential recovery of up to $10M from an existing policy; timing and amount uncertain, not yet recognized.

Business-Segment Outlook:

• DreamSoc (Foundation Product): Remains the primary revenue driver (70% of business); expected to see demand shifts from the halted camera bundles, with some Duo sales migrating to standalone Soc sales during the transition.
• DreamSight & DreamDuo: Sales halted in retail channels pending replenishment with new enclosed cable guards; fully available on OwletCare.com with new guards; no safety issues with the camera hardware itself, only the accessory.
• Owlet 360 Subscriptions:
  • Growth: Ending Q3 2026 with 142,000 paying subscribers (up 83% YoY); MRR $1.3M; penetration rate 36% for US DreamSoc users.
  • Trends: Annual signups nearly tripled QoQ; annual plans now 13% of base (up from 8% in June).
  • New Channels: Expanded subscription availability to retail (Amazon bundle: 3 months with device) and BabyList; testing "web pay" for broader rollout.
• Product Launches:
  • Smart Thermometer: Launched in Q3 2026 (US); FDA-registered; aims to increase daily app engagement and expand the connected health platform; international rollout pending.
  • Owlet One: Testing phase showing 4x conversion rate vs. non-promotional DreamSoc; designed to lower upfront cost with monthly subscription; expected to roll out broadly over the coming months.
  • AI Features: "Morning Report" live in 13 languages; "Nap Schedule," "Nap Timers," and "One-Tap Logging" in development for daily engagement.
  • Owlet on Call: Three new features (weekly health snapshots, daily journaling, visit note-taker) and "Night Watch" (24/7 pediatrician access) rolling out late 2026 into 2027.
• International: Q3 revenue $8M; sell-through grew 23% YoY (adjusted for Prime Day shift); viewed as a growth driver alongside US expansion.

Market and Competitive Outlook:

• Regulatory Environment: Amazon removed all non-compliant third-party monitors by end of September 2026; Owlet remains the only FDA-cleared vital sign monitor on the platform, creating a durable long-term advantage.
• Pricing & Promotion: Q3 saw aggressive competitor discounting ahead of FDA deadlines; Amazon Prime Big Deal Days (Oct) showed 15% YoY growth in US sell-through units, with DreamSoc up 48%.
• Distribution: Registry additions up 59% YoY; viral "baby list gifting" trend supported Q3 growth; strong early start to Q4.
• Competitive Positioning: Owlet positioning itself as the only "truly safe" camera solution with the new enclosed cable guard system, differentiating from competitors lacking this specific safety innovation.

Macro / Industry Outlook:

• Economic/Consumer Trends: Management cites strong consumer demand signals (registry activity, holiday event performance) despite broader macro uncertainties.
• FDA Regulation: The FDA clearance deadline for vital signs monitors has cleared the market of non-compliant competitors, solidifying Owlet's market position.
• Safety Standards: Anticipates the industry shifting toward higher safety standards; Owlet expects to set the new benchmark with the free replacement program.

Strategic Initiatives:

• Safety Retrofit Program: Free replacement of cable guards for all qualified camera owners; transition from loose cables to pre-locked, enclosed interlocking segments; no other baby monitor currently offers this feature.
• Channel Restructuring: Retailers instructed to stop shipping existing units; new SKUs being prepared for restock upon replenishment of new cable guard systems.
• Platform Expansion: Moving from a "night-only" utility to an "everyday" health platform via Smart Thermometer, Nap tracking, and AI features to drive retention and LTV.
• M&A/Partnerships: No M&A mentioned; focus on organic product development and retail partnerships (Amazon, BabyList).

Risks and Headwinds to Outlook:

• Demand Uncertainty: Potential unquantified impact on Q4 demand due to safety news and temporary retail stop-sales; range of outcomes too wide to guide Q4 specifically.
• Logistical Delays: Timing of retailer replenishment depends on manufacturing ramp-up, retailer acceptance, and order timing.
• Insurance Recovery: No guarantee of full or partial recovery from the $10M insurance policy; terms and conditions apply.
• Brand Risk: Short-term noise and headwinds regarding brand reputation due to the child safety incident; however, management views proactive safety measures as a long-term trust builder.
• Cost Variance: Direct program costs ($7–$10M) are estimates dependent on the number of customers requesting replacements.

Management Tone on the Future:

• Confidence: High confidence in the long-term opportunity and business foundation, citing positive operating income, cash flow, and subscription growth.
• Commitment: Fiercely moving forward with the mission of safety; describes the safety update as the "right decision" despite near-term disruption.
• Hedging: Acknowledges "unknowns" and "range of outcomes" for Q4, necessitating the withdrawal of full-year guidance, but explicitly states fundamentals remain strong for 2027.
• Tone: Empathetic regarding the safety incident, decisive on the recall, and optimistic about the resulting competitive moat and product innovation.

Miscellaneous:

• Liquidity: $31.6M cash equivalents + $7.9M credit facility availability = ~$39.5M total liquidity as of Q3 2026.
• Market Cap/Share Data: No specific share count or dividend guidance mentioned.
• Tax Rate: No specific tax rate guidance provided.
• Capex/Opex: Operating expenses at 49.9% of revenue for Q3; prioritizing operational efficiency.